Overweight or Obesity Clinical Trials in Dallas, Texas
2 recruitingDallas, Texas
Showing 1–2 of 2 trials
Recruiting
Phase 4
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
PsoriasisOverweight or Obesity
Eli Lilly and Company200 enrolled43 locationsNCT06857942
Recruiting
Healthy Living BEYOND Weight Study
Overweight or Obesity
American Heart Association1,000,000 enrolled1 locationNCT07075341